Integrated Biosciences
PrivateLast Round
Series B
Jul 21, 2026
Total Funding Raised
$17.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Integrated Biosciences operates in Healthcare & Life Sciences and is based in Redwood City, California. Its latest recorded funding round was a Seed round in October 2024.
Integrated Biosciences is a biotechnology company that develops next-generation therapeutics for age-related diseases by combining synthetic biology, artificial intelligence, and optogenetics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Integrated Biosciences Comparables
Compare Integrated Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transcripta Bio | 86% | |
| Gero | 84% | |
| Genesis Therapeutics | 82% |
For institutional investors. Book with your work email.
Integrated Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 21, 2026 | ||||
| Seed | Oct 3, 2024 |
For institutional investors. Book with your work email.
Integrated Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Polymath | Seed |
| Root Ventures | Seed |
| Illumina Ventures Labs | Seed |
| SH Fund | Seed |
| Conscience VC | Seed |
| Mission BioCapital | Seed |
| LifeSpan Vision Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 21, 2026
$68M round completed.
- Feb 19, 2026
Tony Wu, Co-Founder of xAI, joins the board.
For institutional investors. Book with your work email.
Integrated Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Integrated Biosciences's valuation, stock price, and market status.
Is Integrated Biosciences a public or private company?
Integrated Biosciences is a private company.
What is the current stock price of Integrated Biosciences?
Integrated Biosciences is a private company, so its shares have no public market price. Caplight tracks Integrated Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Integrated Biosciences worth (valuation)?
Valuation information for Integrated Biosciences is not publicly available.
Can I buy Integrated Biosciences stock?
Integrated Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Integrated Biosciences's last funding round?
Integrated Biosciences's most recent funding round was Series B on July 21, 2026.
Who are the main investors in Integrated Biosciences?
Key investors in Integrated Biosciences include Sutter Hill Ventures.
Will Integrated Biosciences IPO soon?
No public IPO plans have been announced for Integrated Biosciences.
How can I track Integrated Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Integrated Biosciences's shares on secondary markets.